Healthcare Research – Desk Research Healthcare Research: We are looking for a desk research/secondary research /medical research who can pull out the number of procedures/surgeries performed and how many hospitals… Read More
Inquiry roundup- Medical Imaging
Medical Imaging Integration And Automation I am researching medical imaging integration and automation. Basically, I want to understand the distribution and sharing process of patients imaging records for diagnosis and… Read More
Inquiry Roundup – Pharmaceutical Industry
Pharmaceutical Grade Mannitol We are looking for experts who has an immense knowledge for pharmaceutical grade Mannitol. Inputs that we are looking are: Global market size by volume and value,… Read More
Cardiac Issues Associated with High-Dose Drug Trial
Last week, Teva Pharmaceutical Industries Ltd. and Active Biotech AB announced they were ending the higher-dose portions of two multiple-sclerosis medication studies. The decision came after eight patients suffered nonfatal… Read More
Teva Halts Studies for Multiple Sclerosis Drug
Teva Pharmaceutical Industries Ltd. and Active Biotech AB recently announced changes to two current drug studies after eight patients suffered “nonfatal cardiovascular events” during phases 2 and 3 of a… Read More
More Funding Available for Life Science Startups
Applications are currently being accepted at MLSC’s website with a deadline of 12:00 p.m. EDT February 5, 2016. Massachusetts is investing $1 billion to expand the life sciences ecosystem in… Read More
Inquiry roundup- Medical Devices.
Medical Device Marketing I am looking for a Marketing expert on Medical Device Business. View Inquiry Ultrasound Imaging I am seeking experts with experience and market knowledge regarding ultrasound-guided needle… Read More
Inquiry Roundup – Biotech
OPEX Management Subject: Expert Request OPEX Management in Plasma DNA Pharma Product Companies Hope this message finds you well! We have a new research project that may fall within your… Read More
Massachusetts’ Role in the Biotech Market: Follow Up
Last summer, Zintro spoke with experts about the steps being taken to increase the number of biotech companies in Massachusetts. In June, a state agency approved $2.2 million in grants… Read More
Premature Babies to Benefit from 3-D Printing Technology
We spoke with Zintro expert Scott Bork in August about the FDA approval of Spritam, the first 3D printed drug, designed to treat seizures brought on by epilepsy in children… Read More
Google Life Sciences Targeting Diabetes–Part II
Last month, Zintro experts responded to the September announcement by Google Life Sciences that it’s researching new therapies to improve diabetes care in collaboration with French multinational pharmaceutical company Sanofi…. Read More
European Life Sciences Companies Turn to Crowdfunding
According to a new report, European life science companies are finding crowdfunding to be a good means of raising quick cash, if not a replacement for angels or VCs. ‘Analysis… Read More
What Does Zarxio Launch Mean for the Future of Biosimilar Drugs?
Last month, Novartis kicked off a new era in U.S. medicine, launching Zarxio, a biosimilar copy of Neupogen–Amgen’s white blood cell-boosting drug. Zarxio is the first biosimilar copy of a… Read More
First Up for Google Life Sciences–Tackling Diabetes
Last month, Google announced that it was creating a new holding company called Alphabet and spinning off all non-core activities from the Google brand–including life sciences work inside Google X…. Read More
Ebola Vaccine Begins Distribution
Last month, preliminary results on an Ebola vaccine in Guinea suggested it was 100 percent effective against the disease. As a result, Doctors Without Borders began to recommend distribution of… Read More